Comment on 'Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer'-No support for de-escalation of immunotherapy

被引：1
作者：
Georgiou, Alexandros [1 ]
Minchom, Anna [1 ]
O'Brien, Mary [1 ]
机构：
[1] Royal Marsden Hosp Fdn Trust, London, England
来源：
EUROPEAN JOURNAL OF CANCER | 2019年 / 115卷
关键词：
DOCETAXEL; NIVOLUMAB; ATEZOLIZUMAB;
D O I：
10.1016/j.ejca.2019.04.011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：24 / 26
页数：3
相关论文
共 50 条
[21]   Impact of corticosteroids on the efficacy of first-line pembrolizumab plus chemotherapy in patients with advanced non-small-cell lung cancer [J].
Roboubi, Amytis ;
Wasielewski, Eric ;
Bordier, Soraya ;
Turlotte, Amelie ;
Pavaut, Geoffrey ;
Scherpereel, Arnaud ;
Cortot, Alexis ;
Gauvain, Clement .
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2025, 17
[22]   Erlotinib Plus Either Pazopanib or Placebo in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer: A Randomized, Placebo-Controlled Phase 2 Trial With Correlated Serum Proteomic Signatures [J].
Spigel, David R. ;
Burris, Howard A., III ;
Greco, F. Anthony ;
Shih, Kent C. ;
Gian, Victor G. ;
Lipman, Andrew J. ;
Daniel, Davey B. ;
Waterhouse, David M. ;
Finney, Lindsey ;
Heymach, John V. ;
Hainsworth, John D. .
CANCER, 2018, 124 (11) :2355-2364
[23]   Final Analysis of a Phase II Study: Anlotinib Plus Docetaxel in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer [J].
Shen, J. ;
Huang, J. ;
Li, X. ;
Xia, B. ;
Wang, B. ;
Yang, S. ;
Wu, K. ;
Zhang, M. ;
Wang, J. ;
Zhao, P. ;
Chen, X. ;
Ma, S. .
JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) :S467-S468
[24]   Phase II Study of Docetaxel-plus-Bevacizumab Combination Therapy in Patients Previously Treated for Advanced Non-squamous Non-small Cell Lung Cancer [J].
Ohyanagi, Fumiyoshi ;
Yanagitani, Noriko ;
Kudo, Keita ;
Kawano, Yuko ;
Sakatani, Toshio ;
Tanimoto, Azusa ;
Nishizawa, Hironari ;
Horiike, Atsushi ;
Hagiwara, Sachiko ;
Horai, Takeshi ;
Nishio, Makoto .
ANTICANCER RESEARCH, 2014, 34 (09) :5153-5158
[25]   Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): A randomized, double-blind, phase III trial [J].
Hanna, Nasser H. ;
Kaiser, Rolf ;
Sullivan, Richard N. ;
Aren, Osvaldo Rudy ;
Ahn, Myung-Ju ;
Tiangco, Beatrice ;
Voccia, Isabelle ;
von Pawel, Joachim ;
Kovcin, Vladimir ;
Agulnik, Jason ;
Gaschler-Markefski, Birgit ;
Barrueco, Jose ;
Sikken, Patricia ;
Schloss, Charles ;
Kim, Joo-Hang .
LUNG CANCER, 2016, 102 :65-73
[26]   KEYNOTE-032: A Randomized Phase I Study of Pembrolizumab in Chinese Patients with Advanced Non-Small Cell Lung Cancer [J].
Ma, Yuxiang ;
Fang, Wenfeng ;
Zhang, Yang ;
Yang, Yunpeng ;
Hong, Shaodong ;
Zhao, Yuanyuan ;
Xie, Shuang ;
Ge, Jun ;
Zhou, HaoJin ;
Zhao, Hongyun ;
Zhang, Li .
ONCOLOGIST, 2020, 25 (08) :650-+
[27]   Statins improve survival in patients previously treated with nivolumab for advanced non-small cell lung cancer: An observational study [J].
Omori, Miwako ;
Okuma, Yusuke ;
Hakozaki, Taiki ;
Hosomi, Yukio .
MOLECULAR AND CLINICAL ONCOLOGY, 2019, 10 (01) :137-143
[28]   Tislelizumab plus chemotherapy versus pembrolizumab plus chemotherapy for the first-line treatment of advanced non-small cell lung cancer: systematic review and indirect comparison of randomized trials [J].
Guo, Yimeng ;
Jia, Junting ;
Hao, Zhiying ;
Yang, Jing .
FRONTIERS IN PHARMACOLOGY, 2023, 14
[29]   Real-world comparison of neoadjuvant pembrolizumab plus chemotherapy versus tislelizumab plus chemotherapy in patients with resectable non-small cell lung cancer: a retrospective cohort study of treatment outcomes [J].
Hu, Yan ;
Ren, Siying ;
Feng, Juan ;
Zeng, Chao ;
Yang, Lulu ;
Liu, Jinyou ;
Wu, Fang ;
Liu, Wenliang .
TRANSLATIONAL LUNG CANCER RESEARCH, 2025, 14 (02) :467-479
[30]   Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non-small cell lung cancer patients [J].
Shiono, Ayako ;
Kaira, Kyoichi ;
Mouri, Atsuto ;
Yamaguchi, Ou ;
Hashimoto, Kosuke ;
Uchida, Takahiro ;
Miura, Yu ;
Nishihara, Fuyumi ;
Murayama, Yoshitake ;
Kobayashi, Kunihiko ;
Kagamu, Hiroshi .
THORACIC CANCER, 2019, 10 (04) :775-781
12345